Oscar Health
U.S. health insurance company
OSCR NYSE
ISIN US6877931096 SEC CIK 1568651
Follow Oscar Health
Weekly email: filings, results
Revenue, last quarter
$6.3M
−28.5% vs same quarter last year
Net income
$167.3M
+221.7% vs same quarter last year
EPS, diluted
$0.49
+192.5% vs same quarter last year
Operating cash flow
−$1.2B
−24.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $28.6M | −$443.2M |
| FY24 | $20.6M | $25.4M |
| FY23 | $21.4M | −$270.7M |
| FY22 | $64.9M | −$606.3M |
| FY21 | $5.4M | −$572.6M |
| FY20 | $0 | −$406.8M |
| FY19 | $488.2M | −$261.2M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −1386.2% | −1549.9% |
| FY24 | 278.3% | 123.6% |
| FY23 | −1103.4% | −1267.9% |
| FY22 | −908.5% | −933.8% |
| FY21 | −10094.2% | −10615.6% |
| FY20 | - | - |
| FY19 | −53.1% | −53.5% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $1.1B |
| FY24 | $950.3M |
| FY23 | −$297.7M |
| FY22 | $351.3M |
| FY21 | −$207.6M |
| FY20 | $208.7M |
| FY19 | −$191.4M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | $0 |
| FY20 | $0 |
| FY19 | $3M |
- Oscar Health
- Financials median
Show the numbers
| Year | Oscar Health | Financials median |
|---|---|---|
| FY25 | −1549.9% | 12.6% |
| FY24 | 123.6% | 13.7% |
| FY23 | −1267.9% | 11.5% |
| FY22 | −933.8% | 12.8% |
| FY21 | −10615.6% | 18.9% |
| FY20 | - | 13.3% |
| FY19 | −53.5% | 14.4% |